SCHEMBL9631247

SCHEMBL9631247

c1ccc(CC2CCCN3C[C@@H]4C[C@@H](CN5CCCC[C@H]45)[C@H]23)cc1

nearest known ligand 0.51

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 4/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ LMNA P02545 1/20 0.51
▸ SLC18A3 Q16572 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ SIGMAR1 Q99720 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9630710 0.83 SIGMAR1 (0.45) CYP2D6MEN1KMT2ALMNAKDM4E
SCHEMBL10525157 0.77 CYP2D6 (0.56) CYP2D6MEN1KMT2ALMNASLC18A3
SCHEMBL248803 0.76 TDP1 (0.51) SLC18A3SIGMAR1
SCHEMBL9631240 0.74 CYP2D6 (0.44) CYP2D6MEN1KMT2ALMNASLC18A3
Sparteine SCHEMBL18468288 0.72 CYP2D6 (1.00) CYP2D6MEN1KMT2ALMNASLC18A3
Sparteine SCHEMBL12301225 0.72 CYP2D6 (1.00) CYP2D6MEN1KMT2ALMNASLC18A3
Sparteine SCHEMBL1753344 0.72 CYP2D6 (1.00) CYP2D6MEN1KMT2ALMNASLC18A3
Sparteine SCHEMBL14331495 0.72 CYP2D6 (1.00) CYP2D6MEN1KMT2ALMNASLC18A3
Sparteine SCHEMBL22619501 0.72 CYP2D6 (1.00) CYP2D6MEN1KMT2ALMNASLC18A3
Sparteine SCHEMBL14029290 0.72 CYP2D6 (1.00) CYP2D6MEN1KMT2ALMNASLC18A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0273272-B1 PHARMACEUTICAL COMPOSITIONS CONTAINING 17-BENZYL SPARTEINE DERIVATIVES WITH A POSITIVE INOTROPIC EFFECT Kali-Chemie Pharma GmbH (DE) 1992-05-06 — — EP claimed
EP-0206155-B1 AROMATIC COMPOUNDS, THEIR PREPARATION AND USE Kali-Chemie Pharma GmbH (DE) 1989-10-18 — — EP claimed
EP-0273272-B1 PHARMACEUTICAL COMPOSITIONS CONTAINING 17-BENZYL SPARTEINE DERIVATIVES WITH A POSITIVE INOTROPIC EFFECT Kali-Chemie Pharma GmbH (DE) 1992-05-06 — — EP disclosed
EP-0273272-A2 Pharmaceutical compositions containing 17-benzyl sparteine derivatives with a positive inotropic effect Kali-Chemie Pharma GmbH (DE) 1988-07-06 — — EP disclosed
Send feedback